A detailed history of Ellis Investment Partners, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ellis Investment Partners, LLC holds 5,813 shares of JAZZ stock, worth $719,242. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,813
Previous 5,925 1.89%
Holding current value
$719,242
Previous $632,000 2.37%
% of portfolio
0.13%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$100.57 - $116.37 $11,263 - $13,033
-112 Reduced 1.89%
5,813 $647,000
Q2 2024

Aug 06, 2024

SELL
$103.94 - $118.98 $340,923 - $390,254
-3,280 Reduced 35.63%
5,925 $632,000
Q1 2024

Apr 15, 2024

BUY
$115.19 - $132.77 $85,816 - $98,913
745 Added 8.81%
9,205 $1.11 Million
Q4 2023

Jan 29, 2024

BUY
$114.26 - $136.0 $342 - $408
3 Added 0.04%
8,460 $1.04 Million
Q3 2023

Nov 01, 2023

SELL
$122.0 - $145.31 $15,860 - $18,890
-130 Reduced 1.51%
8,457 $1.09 Million
Q2 2023

Aug 07, 2023

SELL
$122.5 - $147.16 $27,072 - $32,522
-221 Reduced 2.51%
8,587 $1.06 Million
Q4 2022

Jan 31, 2023

SELL
$129.72 - $159.85 $108,316 - $133,474
-835 Reduced 8.66%
8,808 $1.4 Million
Q2 2022

Aug 01, 2022

SELL
$141.59 - $168.66 $7,079 - $8,433
-50 Reduced 0.52%
9,643 $1.5 Million
Q1 2022

May 03, 2022

BUY
$129.64 - $160.7 $69,616 - $86,295
537 Added 5.87%
9,693 $1.51 Million
Q4 2021

Feb 01, 2022

SELL
$119.87 - $145.67 $301,832 - $366,797
-2,518 Reduced 21.57%
9,156 $1.17 Million
Q3 2021

Oct 21, 2021

BUY
$128.64 - $184.79 $228,850 - $328,741
1,779 Added 17.98%
11,674 $1.52 Million
Q2 2021

Jul 26, 2021

BUY
$160.2 - $186.42 $480 - $559
3 Added 0.03%
9,895 $1.76 Million
Q1 2021

May 03, 2021

SELL
$150.19 - $173.5 $77,197 - $89,179
-514 Reduced 4.94%
9,892 $1.63 Million
Q4 2020

Jan 20, 2021

SELL
$140.71 - $165.05 $322,366 - $378,129
-2,291 Reduced 18.04%
10,406 $1.72 Million
Q3 2020

Oct 19, 2020

BUY
$105.46 - $144.13 $19,299 - $26,375
183 Added 1.46%
12,697 $1.81 Million
Q2 2020

Jul 13, 2020

BUY
$95.68 - $121.88 $81,328 - $103,598
850 Added 7.29%
12,514 $1.37 Million
Q1 2020

Apr 17, 2020

BUY
$87.74 - $152.74 $128,100 - $223,000
1,460 Added 14.31%
11,664 $1.12 Million
Q4 2019

Jan 07, 2020

BUY
$117.65 - $153.73 $119,414 - $156,035
1,015 Added 11.05%
10,204 $1.51 Million
Q3 2019

Oct 09, 2019

BUY
$125.18 - $143.24 $464,793 - $531,850
3,713 Added 67.8%
9,189 $1.16 Million
Q2 2019

Jul 24, 2019

BUY
$125.55 - $144.48 $687,511 - $791,172
5,476 New
5,476 $778,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ellis Investment Partners, LLC Portfolio

Follow Ellis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.